Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A

BSX.PRA

Market cap $973M

BSX.PRA Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q3 2023, worth a combined $0 — down 100% from $32.4K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BSX.PRA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Laffer Tengler Investments, exiting entirely with an estimated $32.4K sold.

• 0 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q3 2023, down from 1 in Q2 2023.
• Funds reported $0 of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q3 2023, down 100% quarter-over-quarter.
• 0 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q3 2023 and 1 closed out, a net change of -1 holder.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q3 2023 was Laffer Tengler Investments, an estimated $32.4K sold.

Based on aggregated 13F filings for Q3 2023.